Cargando…
Validation of an Abridged Breast Cancer Risk Prediction Model for the General Population
Accurate breast cancer risk prediction could improve risk-reduction paradigms if thoughtfully used in clinical practice. Identification of at-risk women is the first step in tailoring risk screening and risk-reduction protocols to women's needs. Using the UK Biobank, we validated a simple risk...
Autores principales: | Spaeth, Erika L., Dite, Gillian S., Hopper, John L., Allman, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150247/ https://www.ncbi.nlm.nih.gov/pubmed/36862830 http://dx.doi.org/10.1158/1940-6207.CAPR-22-0460 |
Ejemplares similares
-
Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk
por: Allman, Richard, et al.
Publicado: (2023) -
Ability of known colorectal cancer susceptibility SNPs to predict colorectal cancer risk: A cohort study within the UK Biobank
por: Gafni, Aviv, et al.
Publicado: (2021) -
Validation of a clinical and genetic model for predicting severe COVID-19
por: Dite, Gillian S., et al.
Publicado: (2022) -
A combined clinical and genetic model for predicting risk of ovarian cancer
por: Dite, Gillian S., et al.
Publicado: (2022) -
Validation of a genetic risk score for Arkansas women of color
por: Starlard-Davenport, Athena, et al.
Publicado: (2018)